Latest news with #CTS
Business Upturn
4 days ago
- Business
- Business Upturn
Blue Biofuels Strengthens Intellectual Property Portfolio with Issuance of New U.S. Patent
PALM BEACH GARDENS, FL, June 18, 2025 (GLOBE NEWSWIRE) — Blue Biofuels, Inc. (OTCQB: BIOF). Blue Biofuels is proud to announce the issuance of a new United States patent, further strengthening the company's expanding intellectual property portfolio. This latest patent brings the company's total number of granted patents to seven, with an additional 25 patent applications pending. Together, they form a robust IP foundation that underscores Blue Biofuels' commitment to safeguarding its pioneering biofuel technologies. The newly granted patent marks a significant milestone in the evolution of our proprietary process, which continues to advance in efficiency, scalability, and innovation. As our technology becomes increasingly sophisticated, the importance of securing comprehensive intellectual property protections grows, ensuring that our breakthroughs remain protected as we move toward commercial deployment. Building upon previously issued patents, this latest addition reinforces Blue Biofuels' leadership in the renewable energy sector and highlights our dedication to pushing the boundaries of sustainable fuel innovation. 'This new patent is a testament to the strength and originality of our CTS technology,' said Ben Slager, CEO of Blue Biofuels. 'Each step forward in building our intellectual property portfolio is a step toward securing our competitive advantage as we bring clean, cost-effective biofuels to market. Innovation and protection go hand-in-hand as we scale up.' As we continue to enhance and commercialize our technology, securing the intellectual assets that support our long-term growth and leadership remains a top priority. This new patent further positions Blue Biofuels at the forefront of the domestic clean energy transition. About Blue Biofuels, Inc. Blue Biofuels is based in Florida and has the goal to produce biofuels through its patented Cellulose-to-Sugar (CTS) technology and its licensed Vertimass technology as well as in VertiBlue Fuels, LLC, its 50:50 joint venture with Vertimass. CTS is a sustainable, and renewable green energy system with the potential to achieve a near-zero carbon footprint. The CTS process can convert cellulose from virtually any plant material – grasses, forestry products, and agricultural waste such as sugarcane bagasse and wheat straw — into sugars that are subsequently processed into biofuels, such as ethanol and, through the Vertimass Process, into sustainable aviation fuel. The CTS process is a patented and proprietary technology wholly owned by Blue Biofuels. Blue Biofuels' CTS technology represents significant progress in renewable energy, offering a sustainable solution that reduces reliance on food crops for ethanol production. By utilizing abundant and renewable biomass sources such as king grass, sugar cane bagasse, and corn stover, the company is positioned to contribute meaningfully to the global transition toward cleaner energy. This versatility allows the company to take advantage of feedstock variability in different locations around the US and the world. Special Note Regarding Forward-Looking Statements This press release contains 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties, and other important factors that could cause the Company's actual results, performance, or achievements or industry results to differ materially from any future results, performance, or achievements expressed or implied by these forward-looking statements. These statements are subject to a number of risks and uncertainties, many of which are beyond the Company's control. The words 'believes', 'may', 'will', 'should', 'would', 'could', 'continue', 'seeks', 'anticipates', 'plans', 'expects', 'intends', 'estimates', or similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. Any forward-looking statements included in this press release are made only as of the date of this release. The Company does not undertake any obligation to update or supplement any forward-looking statements to reflect subsequent events or circumstances. The Company cannot assure you that the projected results or events will be achieved. Contact: Ben Slager, CEO and Chairman [email protected]
Yahoo
4 days ago
- Business
- Yahoo
Estimating The Fair Value Of CTS Corporation (NYSE:CTS)
The projected fair value for CTS is US$47.18 based on 2 Stage Free Cash Flow to Equity CTS' US$41.48 share price indicates it is trading at similar levels as its fair value estimate Today we will run through one way of estimating the intrinsic value of CTS Corporation (NYSE:CTS) by estimating the company's future cash flows and discounting them to their present value. The Discounted Cash Flow (DCF) model is the tool we will apply to do this. It may sound complicated, but actually it is quite simple! We generally believe that a company's value is the present value of all of the cash it will generate in the future. However, a DCF is just one valuation metric among many, and it is not without flaws. For those who are keen learners of equity analysis, the Simply Wall St analysis model here may be something of interest to you. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company's cash flows. Generally the first stage is higher growth, and the second stage is a lower growth phase. To begin with, we have to get estimates of the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years. Generally we assume that a dollar today is more valuable than a dollar in the future, so we need to discount the sum of these future cash flows to arrive at a present value estimate: 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 Levered FCF ($, Millions) US$67.7m US$77.6m US$76.8m US$76.9m US$77.7m US$78.9m US$80.5m US$82.3m US$84.3m US$86.5m Growth Rate Estimate Source Analyst x1 Analyst x1 Est @ -1.02% Est @ 0.17% Est @ 1.00% Est @ 1.58% Est @ 1.99% Est @ 2.27% Est @ 2.47% Est @ 2.61% Present Value ($, Millions) Discounted @ 7.7% US$62.8 US$66.8 US$61.4 US$57.1 US$53.5 US$50.4 US$47.7 US$45.3 US$43.1 US$41.0 ("Est" = FCF growth rate estimated by Simply Wall St)Present Value of 10-year Cash Flow (PVCF) = US$529m We now need to calculate the Terminal Value, which accounts for all the future cash flows after this ten year period. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 2.9%. We discount the terminal cash flows to today's value at a cost of equity of 7.7%. Terminal Value (TV)= FCF2034 × (1 + g) ÷ (r – g) = US$87m× (1 + 2.9%) ÷ (7.7%– 2.9%) = US$1.9b Present Value of Terminal Value (PVTV)= TV / (1 + r)10= US$1.9b÷ ( 1 + 7.7%)10= US$879m The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is US$1.4b. The last step is to then divide the equity value by the number of shares outstanding. Compared to the current share price of US$41.5, the company appears about fair value at a 12% discount to where the stock price trades currently. Valuations are imprecise instruments though, rather like a telescope - move a few degrees and end up in a different galaxy. Do keep this in mind. We would point out that the most important inputs to a discounted cash flow are the discount rate and of course the actual cash flows. If you don't agree with these result, have a go at the calculation yourself and play with the assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at CTS as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 7.7%, which is based on a levered beta of 1.110. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business. View our latest analysis for CTS Strength Earnings growth over the past year exceeded the industry. Debt is not viewed as a risk. Weakness Earnings growth over the past year is below its 5-year average. Dividend is low compared to the top 25% of dividend payers in the Electronic market. Opportunity Annual earnings are forecast to grow for the next 2 years. Current share price is below our estimate of fair value. Threat No apparent threats visible for CTS. Whilst important, the DCF calculation ideally won't be the sole piece of analysis you scrutinize for a company. It's not possible to obtain a foolproof valuation with a DCF model. Instead the best use for a DCF model is to test certain assumptions and theories to see if they would lead to the company being undervalued or overvalued. For example, changes in the company's cost of equity or the risk free rate can significantly impact the valuation. For CTS, there are three additional factors you should assess: Financial Health: Does CTS have a healthy balance sheet? Take a look at our free balance sheet analysis with six simple checks on key factors like leverage and risk. Future Earnings: How does CTS's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart. Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered! PS. Simply Wall St updates its DCF calculation for every American stock every day, so if you want to find the intrinsic value of any other stock just search here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Vancouver Sun
12-06-2025
- Health
- Vancouver Sun
Canadians still waiting longer for surgeries than before COVID
The massive surgical backlogs left after rolling pandemic lockdowns are clearing but Canadians are still waiting longer than they were pre-COVID for new hips and knees, cancer surgeries and other 'priority' procedures, new data show. Even though 26 per cent more hip and knee replacements were done in 2024 than 2019, it still wasn't enough to meet the need: just 68 per cent of Canadians received a hip replacement within the 26-week benchmark last year, compared to 75 per cent in 2019. For those needing a knee replacement, 61 per cent got a slot in the operating room within the 182-day threshold, compared with 70 per cent in 2019, even though 21 per cent more knee replacements were performed in 2024 than in 2019. Start your day with a roundup of B.C.-focused news and opinion. By signing up you consent to receive the above newsletter from Postmedia Network Inc. A welcome email is on its way. If you don't see it, please check your junk folder. The next issue of Sunrise will soon be in your inbox. Please try again Interested in more newsletters? Browse here. Median wait times for breast, bladder, colorectal, lung and prostate cancer surgery also rose, with prostate cancer seeing the biggest bump in wait times, an extra nine days over 2019. Wait times for scans to diagnose diseases and injuries also increased, 'with MRI scans requiring an additional 15 days and CTS scans three more days compared with 2019,' the Canadian Institute for Health Information (CIHI) reported in a background release. Canadians waited a median 57 days for an MRI scan in 2024. One in 10 waited 198 days. The longer people wait, the more they deteriorate. Delays getting to an operating room 'can lead to disease progression, increased symptoms of anxiety and depression, risk of mental health flareups and worsening of surgical and nonsurgical patient outcomes,' Canadian researchers have warned. Hospitals across the country pushed back non-urgent surgeries during the early waves of COVID to free up beds. Almost 600,000 fewer operations were performed in the first 22 months of the pandemic alone compared to 2019, CIHI reported. The backlog has meant that by the time people see a surgeon, their problem is more complex than it would have been in the past, Dr. James Howard, chief of orthopedic surgery at University Hospital – London Health Sciences Centre said in the news release. Canada's aging baby boomer generation, with arthritis and other joint conditions, is also putting pressure on the system. 'So even with surgeons collectively working as much as they can and completing more surgeries than we have in the past, we are not seeing wait times come down due to the complexity and volume of patients presenting to orthopedic surgeons,' Howard said. While case numbers are bouncing back — five per cent more surgeries of all types were performed in 2023 than in 2019 — the volumes still haven't kept up with population growth (seven per cent over the same period) or the 10 per cent rise in demand for surgery among those 65 and older, CIHI reported. 'Although an increase in the volume of procedures performed across Canada means that the surgical backlog from the height of the pandemic period has effectively been cleared, ripple effects in the health systems — due in part to the pandemic — persist that impact wait times in Canada,' CIHI's Cheryl Chui, director of health system analytics, said in a statement. Factors driving those longer wait times include a shortage of specialists and nurses, limited operating room time, space and staff, and emergency cases that take priority over scheduled ones. Ontario and other provinces are trying to push through more surgeries and procedures, partly by doing more on an outpatient basis, meaning no overnight hospital stay. Ontario has also announced plans to expand the number of private clinics providing publicly covered hip and knee replacements. Other provinces have done the same, though 'the impact on surgical volumes and wait times is still being assessed,' CIHI said. According to the agency's latest waitlist snapshot, while the number of hip replacements increased from 22,000 in 2019, to 28,000 in 2024, and the number of knee replacements from 35,000 to 42,000 over the same period, a smaller proportion of people received joint replacement surgery within the recommended six months. Nationally, in 2024, only 68 per cent of people needing a new hip were treated within the 26-week benchmark, compared to 75 per cent in 2019. Ontario fared better than all other provinces: 82 per cent of hip replacement patients were treated within that timeframe. Newfoundland and Labrador (41 per cent) and Prince Edward Island (45 per cent) performed the worst. British Columbia (63 per cent), Saskatchewan (50 per cent), Manitoba (54 per cent) and Quebec (49 per cent) also scored below the proportion nationally. In Alberta, 73 per cent of hip replacements were performed within the benchmark in 2024. Ripple effects in the health systems — due in part to the pandemic — persist that impact wait times in Canada Overall, patients waited a median 125 days for hip surgery in 2024 (half waited less, half waited more). One in 10 waited 340 days. For knee replacements, 79 per cent of patients in Ontario received surgery within the 26-week benchmark in 2024, compared to 38 per cent in Quebec, 47 per cent in Saskatchewan, 55 per cent in B.C. and 62 per cent in Alberta. While efforts are being made to better manage and monitor surgical waitlists, researchers have warned that people with severe pain or worsening symptoms aren't being prioritized. Wait times for cataract surgery were close to pre-pandemic levels — 69 per cent of people were treated within a 16-week benchmark in 2024 versus 70 per cent in 2019. The percentage of people who received radiation therapy within 28 days and surgery to repair a fractured hip within 48 hours dropped slightly, by three percentage points from 2019 to 2024, falling to 94 per cent and 83 per cent, respectively. The volume of prostate cancer surgeries performed dropped by three per cent, from 3,500 in 2019, to 3,400 in 2024. And men waited longer for the procedure — from a median 41 days in 2019, to 50 days in 2024. Slower-growing cancers like prostate cancer tend to have the longest surgical wait times, CIHI reported. Median wait times for breast cancer surgery increased from 18 days in 2019 to 23 days in 2024, and wait times for bladder cancer increased from 24 days to 28 days. National Post Our website is the place for the latest breaking news, exclusive scoops, longreads and provocative commentary. Please bookmark and sign up for our daily newsletter, Posted, here .
Scroll.in
11-06-2025
- General
- Scroll.in
TNPSC CTS 2025: Last date to apply for 330 vacancies today; here's direct link
The Tamil Nadu Public Service Commission (TNPSC) is closing the application window today, June 11, 2025, for the Combined Technical Services Examination (Interview Posts) 2025. Interested and eligible candidates who have not yet applied can submit their applications by the end of the day at the official website This recruitment drive aims to fill 330 vacancies across various departments. The TNPSC CTS exam is scheduled to be held from July 20 to July 23, 2025. A correction window will be open from June 15 to June 17, 2025. Steps to apply for TNPSC CTS (Interview Posts) 2025
Yahoo
10-06-2025
- Business
- Yahoo
The Cooperative Logistics Network Celebrates 10 Years of Success at 8th Annual Meeting in Abu Dhabi with 220+ Freight Forwarders in Attendance
The Coop's 8th Annual Meeting - Abu Dhabi From 28th to 30th May 2025, The Cooperative Logistics Network gathered over 220 freight forwarders from more than 70 countries at the Intercontinental Hotel Abu Dhabi for three days of high-impact networking, business development, and Cooperative Logistics Network concluded its 8th Annual Meeting in style, bringing together over 220 top freight forwarders from more than 70 countries for three days of high-impact networking and strategic collaboration. Held from 28th to 30th May at the prestigious Intercontinental Hotel Abu Dhabi, the event marked a significant milestone: a decade of growth, innovation, and global celebration of its 10th anniversary, The Coop honored its founding members—recognizing the critical role they've played in the network's development since its inception. 'When we launched The Cooperative Logistics Network ten years ago, we started with just over 60 cities and a clear mission: to empower independent freight forwarders through cooperation,' said Antonio Torres, President and Founder. 'Today, with 376 members in over 140 countries, that vision is a reality.''Along the way, we've expanded our services significantly—from our digital quoting platform, FreightViewer, to a mobile web app and a new integrated cargo insurance solution developed with Redkik. These tools help members operate more efficiently and stay competitive. With eight successful Annual Meetings and two virtual editions, The Coop continues to grow as a leading force in independent freight forwarding'.Ali Kaddour, Sales Manager of CTS (Customs and Trade Solutions), a founder member of The Cooperative from Sydney, Australia, highlights how the network has influenced their business: 'Our experience with The Cooperative has been very positive. With over 15 years of experience, CTS has developed strong relationships with both clients and partners. The personal connections you build within the network significantly impact your business on a professional level. With the network's support, CTS has expanded internationally, growing our business and strengthening our local operations.'The conference offered a dynamic platform for business development, with hundreds of pre-scheduled one-to-one meetings generating new commercial opportunities. While many freight networks continue expanding, The Coop remains committed to limiting membership per city, preserving its core philosophy of close-knit collaboration. This unique scale — not too small, but deliberately not too large — fosters meaningful relationships that go beyond business and drive long-term the event, attendees explored next-generation digital tools designed to support modern freight forwarders. The upgraded FreightViewer platform was demonstrated live, showcasing new functionalities and a more intuitive interface. Additionally, The Coop officially launched its integrated cargo insurance program in partnership with Redkik, enabling members to manage shipments and coverage through a single business, the program featured curated moments for networking and cultural exchange, including a guided tour of Abu Dhabi's architectural landmarks, a stylish welcome reception, and a memorable gala dinner with live high engagement and overwhelmingly positive feedback, The Cooperative Logistics Network now turns its focus to the 2026 Annual Meeting, which promises even more innovation, connectivity, and opportunity. This year's event not only celebrated the past decade but also set the tone for a future driven by technology, trust, and true collaboration. For further information kindly contact:Maria SerranoTel. +34 983435107mserrano@ Cooperative Logistics Network is a capped, non-exclusive alliance of more than 376 hand-picked freight forwarders in each major air/seaport who co-operate in a financially secure environment to reduce costs and risks and grow their businesses by actively working together to compete against the largest multinationals. Attachment The Coop's 8th Annual Meeting - Abu Dhabi
